SC 13G Filing

Company

Travere Therapeutics, Inc.

Filed

January 17, 2014

Accession Number

0000919574-14-000310

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →